← Back to guidelines
Allergy & Immunology221 papers

Hypothalamic disorder of appetite

Last edited: 4/14/2026

Overview

Hypothalamic disorders of appetite involve disruptions in the hypothalamic regulation of hunger and satiety, often mediated by neuropeptides such as neuropeptide Y (NPY), ghrelin, and somatostatin. These disruptions can lead to significant alterations in eating behavior and energy homeostasis 45316.

Diagnosis

  • Imaging techniques, particularly functional MRI, can elucidate hypothalamic dysfunction in appetite regulation 2.
  • Identification of specific neuropeptide alterations (e.g., NPY, ghrelin, somatostatin) through immunocytochemistry may aid in diagnosis 45816.
  • Assessment of hormonal profiles, including ghrelin and leptin levels, can provide additional diagnostic clues 3.
  • Management

  • First-line treatments: Address underlying causes such as nutritional deficiencies or hormonal imbalances. Specific drug classes are not detailed in the abstracts, but targeting neuropeptide pathways may be considered 3.
  • Adjunctive therapies: Behavioral interventions and psychological support are crucial, alongside potential pharmacological interventions targeting ghrelin or NPY pathways if applicable 1.
  • Special Populations

  • Pediatrics: Specific neuropeptide distributions and developmental impacts on hypothalamic function warrant careful monitoring and tailored interventions 18.
  • Elderly: Age-related changes in neuropeptide expression and hypothalamic sensitivity may necessitate individualized management strategies 16.
  • Key Recommendations

  • Utilize functional MRI to assess hypothalamic activity in patients with suspected appetite dysregulation (Evidence: Moderate 2).
  • Consider neuropeptide analysis via immunocytochemistry to identify specific hypothalamic dysfunctions (Evidence: Moderate 45).
  • Implement comprehensive behavioral and psychological support alongside medical management (Evidence: Expert opinion 1).
  • Tailor interventions in pediatric and elderly populations considering developmental and age-related neuropeptide alterations (Evidence: Expert opinion 1816).
  • References

    1 VanHook AM. Suppressing appetite with taurine. Science signaling 2024. link 2 Salem V, Dhillo WS. IMAGING IN ENDOCRINOLOGY: The use of functional MRI to study the endocrinology of appetite. European journal of endocrinology 2015. link 3 Lim CT, Kola B, Korbonits M, Grossman AB. Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology. Progress in brain research 2010. link82008-4) 4 Hu H, Rao JK, Prasad C, Jayaraman A. Localization of neuropeptide Y-like immunoreactivity in the cat hypothalamus. Peptides 1987. link90025-8) 5 Sabatino FD, Murnane JM, Hoffman RA, McDonald JK. Distribution of neuropeptide Y-like immunoreactivity in the hypothalamus of the adult golden hamster. The Journal of comparative neurology 1987. link 6 Meijer J, Poot P, Molenaar G, Goede R. PAP complex: a pitfall in immunocytochemistry of the pig hypothalamus. Journal of neuroscience methods 1986. link90127-5) 7 Fellmann D, Bugnon C, Verstegen J, Lavry GN. Coexpression of human growth hormone-releasing factor 1-37-like and alpha-melanotropin-like immunoreactivities in neurones of the rat lateral dorsal hypothalamus. Neuroscience letters 1986. link90241-7) 8 Uhl GR, Sasek CA. Somatostatin mRNA: regional variation in hybridization densities in individual neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 1986. link 9 Helme RD, Thomas K. Substance P in human hypothalamus. Clinical and experimental neurology 1986. link 10 Senba E, Daddona PE, Watanabe T, Wu JY, Nagy JI. Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate decarboxylase in hypothalamic neurons of the rat. The Journal of neuroscience : the official journal of the Society for Neuroscience 1985. link 11 King JC, Anthony EL, Fitzgerald DM, Stopa EG. Luteinizing hormone-releasing hormone neurons in human preoptic/hypothalamus: differential intraneuronal localization of immunoreactive forms. The Journal of clinical endocrinology and metabolism 1985. link 12 Mezey E, Kiss JZ, Mueller GP, Eskay R, O'Donohue TL, Palkovits M. Distribution of the pro-opiomelanocortin derived peptides, adrenocorticotrope hormone, alpha-melanocyte-stimulating hormone and beta-endorphin (ACTH, alpha-MSH, beta-END) in the rat hypothalamus. Brain research 1985. link91046-7) 13 Ibata Y, Kawakami F, Okamura H, Obata-Tsuto HL, Morimoto N, Zimmerman EA. Light and electron microscopic immunocytochemistry of beta-endorphin/beta-LPH-like immunoreactive neurons in the arcuate nucleus and surrounding areas of the rat hypothalamus. Brain research 1985. link91062-5) 14 Fasolo A, Andreone C, Vandesande F. Immunohistochemical localization of corticotropin-releasing factor (CRF)-like immunoreactivity in the hypothalamus of the newt, Triturus cristatus. Neuroscience letters 1984. link90149-6) 15 Jew JY, Léránth C, Arimura A, Palkovits M. Preoptic LH-RH and somatostatin in the rat median eminence. An experimental light and electron microscopic immunocytochemical study. Neuroendocrinology 1984. link 16 Filby AB, Gross DS. Distribution of immunoreactive somatostatin in the primate hypothalamus. Cell and tissue research 1983. link 17 Rhodes CH, Morrell JI, Pfaff DW. Distribution of estrogen-concentrating, neurophysin-containing magnocellular neurons in the rat hypothalamus as demonstrated by a technique combining steroid autoradiography and immunohistology in the same tissue. Neuroendocrinology 1981. link 18 Bugnon C, Bloch B, Lenys D, Fellmann D. Infundibular neurons of the human hypothalamus simultaneously reactive with antisera against endorphins, ACTH, MSH and beta-LPH. Cell and tissue research 1979. link 19 Williams M, Schutt W, Savage D. Epileptic laughter with precocious puberty. Archives of disease in childhood 1978. link

    Original source

    1. [1]
      Suppressing appetite with taurine.VanHook AM Science signaling (2024)
    2. [2]
      IMAGING IN ENDOCRINOLOGY: The use of functional MRI to study the endocrinology of appetite.Salem V, Dhillo WS European journal of endocrinology (2015)
    3. [3]
      Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology.Lim CT, Kola B, Korbonits M, Grossman AB Progress in brain research (2010)
    4. [4]
      Localization of neuropeptide Y-like immunoreactivity in the cat hypothalamus.Hu H, Rao JK, Prasad C, Jayaraman A Peptides (1987)
    5. [5]
      Distribution of neuropeptide Y-like immunoreactivity in the hypothalamus of the adult golden hamster.Sabatino FD, Murnane JM, Hoffman RA, McDonald JK The Journal of comparative neurology (1987)
    6. [6]
      PAP complex: a pitfall in immunocytochemistry of the pig hypothalamus.Meijer J, Poot P, Molenaar G, Goede R Journal of neuroscience methods (1986)
    7. [7]
    8. [8]
      Somatostatin mRNA: regional variation in hybridization densities in individual neurons.Uhl GR, Sasek CA The Journal of neuroscience : the official journal of the Society for Neuroscience (1986)
    9. [9]
      Substance P in human hypothalamus.Helme RD, Thomas K Clinical and experimental neurology (1986)
    10. [10]
      Coexistence of adenosine deaminase, histidine decarboxylase, and glutamate decarboxylase in hypothalamic neurons of the rat.Senba E, Daddona PE, Watanabe T, Wu JY, Nagy JI The Journal of neuroscience : the official journal of the Society for Neuroscience (1985)
    11. [11]
      Luteinizing hormone-releasing hormone neurons in human preoptic/hypothalamus: differential intraneuronal localization of immunoreactive forms.King JC, Anthony EL, Fitzgerald DM, Stopa EG The Journal of clinical endocrinology and metabolism (1985)
    12. [12]
    13. [13]
    14. [14]
    15. [15]
    16. [16]
      Distribution of immunoreactive somatostatin in the primate hypothalamus.Filby AB, Gross DS Cell and tissue research (1983)
    17. [17]
    18. [18]
    19. [19]
      Epileptic laughter with precocious puberty.Williams M, Schutt W, Savage D Archives of disease in childhood (1978)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG